AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio
Go back to AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio| AbbVie (NYSE: ABBV) | Delayed: 258.37 +1.45 (0.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $256.92 | 52 Week High | $68.12 | |||
| Open | $258.54 | 52 Week Low | $50.71 | |||
| Day High | $260.22 | P/E | 56.05 | |||
| Day Low | $256.77 | EPS | $4.61 | |||
| Volume | 2,105,447 | |||||
| Apogee Robotics (NASDAQ: APGE) | Delayed: 134.26 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $134.26 | 52 Week High | $0.02 | |||
| Open | $134.25 | 52 Week Low | $0.02 | |||
| Day High | $134.35 | P/E | N/A | |||
| Day Low | $134.21 | EPS | $0.00 | |||
| Volume | 269,977 | |||||
